WILMINGTON, Del., May 14, 2019 /PRNewswire/ — DuPont today announced a new, comprehensive parental leave policy that offers four weeks of paid leave for new parents, including adoptive and same-sex parents. For birth mothers, the four paid weeks are in addition to an enhanced paid maternity leave which has been extended to 12 weeks. The new policy takes effect on June 1 in the United States and across all global locations no later than the end of 2020.
The policy applies new global minimum leave benefits, ensuring all employees receive at least these levels. Parents have the option of taking their four weeks of paid leave all at one time or intermittently during the first year. The policy also applies for each new child — not just the first.
“We are proud of our employees and when they become a new parent, we are excited to help them thrive at work and at home,” said Marc Doyle, Chief Executive Officer-Elect for DuPont and Chief Operating Officer, DowDuPont Specialty Products Division. “Great companies care about their employees. This policy demonstrates that we care about our employees’ well-being empowering them with the flexibility to make it easier to choose both family and career. What’s more, it will enhance our ability to attract and retain top talent and lead to the continued success of our company as we transform our workplace.”
About DowDuPont Specialty Products Division
DowDuPont Specialty Products, a division of DowDuPont (NYSE: DWDP), is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, building and construction, health and wellness, food and worker safety. DowDuPont intends to separate the Specialty Products Division, which will be called DuPont, into an independent, publicly traded company. More information can be found at www.dow-dupont.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/dupont-enhances-global-parental-leave-policy-300849808.html
SOURCE DuPont
– Pharmacology modeling data presented at the European Academy of Allergy & Clinical Immunology (EAACI)…
D-bal-max D-Bal MAX Glasgow, June 15, 2025 (GLOBE NEWSWIRE) -- In the quest for enhanced…
Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial show investigational treatment…
Results from the Phase 2 RedirecTT-1 study demonstrate deep responses with 78.9 percent overall response…
After a thorough clinical review, the benefit-risk for the use of Elevidys in non-ambulatory patients…
77% of patients (150 mg Q4W) treated with barzolvolimab who had angioedema at baseline were…